US Neurosurgical Holdings Inc
OTC:USNU
US Neurosurgical Holdings Inc
Other
US Neurosurgical Holdings Inc
Other Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
U
|
US Neurosurgical Holdings Inc
OTC:USNU
|
Other
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Universal Health Services Inc
NYSE:UHS
|
Other
$10.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Encompass Health Corp
NYSE:EHC
|
Other
-$173.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
6%
|
CAGR 10-Years
-5%
|
|
|
Tenet Healthcare Corp
NYSE:THC
|
Other
-$919m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-41%
|
CAGR 10-Years
-8%
|
|
|
HCA Healthcare Inc
NYSE:HCA
|
Other
-$1.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-12%
|
|
|
Ensign Group Inc
NASDAQ:ENSG
|
Other
-$2.4m
|
CAGR 3-Years
26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
0%
|
|
US Neurosurgical Holdings Inc
Glance View
U.S.Neurosurgical Holdings, Inc. engages in the business of owning and operating stereotactic radiosurgery centers and holds other interests in radiological treatment facilities. The company is headquartered in Rockville, Maryland. NeuroSurgical Holdings, Inc. is a holding company. The firm owns and operates, through its subsidiaries, stereotactic radiosurgery centers, utilizing gamma knife technology, and holds other interests in radiological treatment facilities. Its subsidiary U.S. NeuroSurgical, Inc. (USN) is a medical services company that partners with hospitals and physicians to own and operate facilities utilizing technologies in medical treatment and/or diagnosis. USN owns and operates one gamma knife center on the premises of New York University Medical Center (NYU) in New York. The firm is focusing on establishing cancer centers using intensity-modulated radiation therapy (IMRT) and/or image-guided radiation therapy (IGRT) in Florida and other parts of the United States. Its gamma knife is a stereotactic radio surgical device used to treat brain tumors and other malformations of the brain without invasive surgery.
